Urinary 3-Methoxytyramine Is a Biomarker for MYC Activity in Patients With Neuroblastoma

Elevated urinary 3-methoxytyramine (3MT) level at diagnosis was recently put forward as independent risk factor for poor prognosis in neuroblastoma. Here, we investigated the biologic basis underlying the putative association between elevated 3MT levels and poor prognosis. METHODS: Urinary 3MT level...

Descripción completa

Detalles Bibliográficos
Autores principales: Verly, Iedan R. N., Matser, Yvette A. H., Leen, René, Meinsma, Rutger, Fiocco, Marta, Koster, Jan, Volckmann, Richard, Savci-Heijink, Dilara, Cangemi, Giuliana, Barco, Sebastiano, Valentijn, Linda J., Tytgat, Godelieve A. M., van Kuilenburg, André B. P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2022
Materias:
Original Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830522/
https://www.ncbi.nlm.nih.gov/pubmed/35085004
http://dx.doi.org/10.1200/PO.20.00447

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830522/
https://www.ncbi.nlm.nih.gov/pubmed/35085004
http://dx.doi.org/10.1200/PO.20.00447

Ejemplares similares